Hospital Medicine

There is not currently an FDA approved treatment for NASH.

Investigators compared the 2010 and 2017 IDSA and SHEA guidelines to identify which better predicted C diff patients’ severity and mortality.

Cabotegravir’s FDA breakthrough designation along with adaptive strategies being deployed are the biggest stories in HIV prevention this year.

The TARGET-NASH study seeks to shed light on treatment for NASH and NAFLD.

Hepatitis B coinfection with COVID-19 did not increase either disease’s severity or increase duration of hospitalization, according to a small study in China.

Using French data, there were 3 times as many deaths from COVID-19 than the Flu in France, despite a shorter study time.

Harvey Alter, Michael Houghton, and Charles Rice were awarded with the 2020 Nobel Prize in Physiology and Medicine.

A study finds that children with cognitive or emotional deficits trended towards an increased healthcare utilization.

Patients with baseline PROMIS-57 scores worse than population norms reported clinically significant improvements in 6 of 8 domains at 12 months post-treatment.

Patients with acute myeloid leukemia or myelodysplastic syndromes are at especially increased risk for increased disease severity and death.

Investigators evaluated patients from 3 Chicago hospital systems and assessed risk factors associated with thrombosis.

High levels of fetal hemoglobin have previously been linked to the mitigation of morbidity and mortality of sickle cell anemia.

Those without prior exposure to venetoclax experienced the most benefit.

This combination therapy may have a few advantages over standard corticosteroid regimens.

Despite the difficult circumstances, experts believe colorectal cancer rates will not decrease in the coming years due to delays in screenings.

New data shows a large shift from mortality due bacterial infection to other sickle cell disease causes, treatment complications, or non-related comorbidities.

Patients with hematological disorders like sickle cell disease or β-thalassemia are at high risk for HCV infection as a result of frequent transfusions.

Guidance based on procalcitonin concentration levels may useful in reducing duration of antibiotic treatment for sickle cell patients with acute chest syndrome.

Raymond Douglas, MD, PhD, discusses data that demonstrate the benefit of teprotumumab in patients with all levels of thyroid eye disease.

There was a substantial increase in drug use-related endogenous endophthalmitis hospitalizations between 2003 and 2016.

Longer studies are needed to determine the effectiveness and durability of CDI interventions.

A dual-guest interview on the current leading research into advanced lung cancer screening and detection.

In data presented at ACG 2020, researchers show a combination of sulindac and eflornithine could be effective for FAP patients.

A new ACG study shows that 18% would have been considered low risk for NASH-F based on FAST score despite having high liver stiffness measurement.

The CDC has standardized guidelines to help diagnose diarrhea, a potential indicator of c. difficile infection.